Literature DB >> 28265128

How We Manage Pediatric Deep Venous Thrombosis.

Marisol Betensky1, Mark A Bittles2, Paul Colombani3, Neil A Goldenberg1.   

Abstract

Over the past two decades, the incidence and recognition of venous thromboembolism (VTE) in children has significantly increased, likely as a result of improvements in the medical care of critically ill patients and increased awareness of thrombotic complications among medical providers. Current recommendations for the management of VTE in children are largely based on data from pediatric registries and observational studies, or extrapolated from adult data. The scarcity of high-quality evidence-based recommendations has resulted in marked variations in the management of pediatric VTE among providers. The purpose of this article is to summarize our institutional approach for the management of VTE in children based on available evidence, guidelines, and clinical practice considerations. Therapeutic strategies reviewed in this article include the use of conventional anticoagulants, parenteral targeted anticoagulants, new direct oral anticoagulants, thrombolysis, and mechanical approaches for the management of pediatric VTE.

Entities:  

Keywords:  anticoagulants; pediatric; thrombolytic therapy; venous thromboembolism

Year:  2017        PMID: 28265128      PMCID: PMC5334487          DOI: 10.1055/s-0036-1597762

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  114 in total

Review 1.  Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.

Authors:  Jeremy W Vandiver; Thomas G Vondracek
Journal:  Pharmacotherapy       Date:  2012-04-24       Impact factor: 4.705

Review 2.  Pulmonary embolism in children.

Authors:  Paul G Thacker; Edward Y Lee
Journal:  AJR Am J Roentgenol       Date:  2015-06       Impact factor: 3.959

3.  Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.

Authors:  C H van Ommen; H Heijboer; H R Büller; R A Hirasing; H S Heijmans; M Peters
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

4.  Endovenous therapy for deep venous thrombosis: the TORPEDO trial.

Authors:  Mohsen Sharifi; Mahshid Mehdipour; Curt Bay; Gary Smith; Jalaladdin Sharifi
Journal:  Catheter Cardiovasc Interv       Date:  2010-09-01       Impact factor: 2.692

Review 5.  Venous thoracic outlet compression and the Paget-Schroetter syndrome: a review and recommendations for management.

Authors:  J F Thompson; R J Winterborn; S Bays; H White; D C Kinsella; A F Watkinson
Journal:  Cardiovasc Intervent Radiol       Date:  2011-03-30       Impact factor: 2.740

6.  Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Authors:  N A Goldenberg; T Abshire; P J Blatchford; L Z Fenton; J L Halperin; W R Hiatt; C M Kessler; J M Kittelson; M J Manco-Johnson; A C Spyropoulos; P G Steg; N V Stence; A G G Turpie; S Schulman
Journal:  J Thromb Haemost       Date:  2015-08-11       Impact factor: 5.824

Review 7.  A guide to the use of anticoagulant drugs in children.

Authors:  Connie Law; Leslie Raffini
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

8.  Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis.

Authors:  Suresh Vedantham; Thomas M Vesely; Gregorio A Sicard; Daniel Brown; Brian Rubin; Luis A Sanchez; Naveen Parti; Daniel Picus
Journal:  J Vasc Interv Radiol       Date:  2004-06       Impact factor: 3.464

9.  Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

Authors:  Leslie Raffini; Yuan-Shung Huang; Char Witmer; Chris Feudtner
Journal:  Pediatrics       Date:  2009-09-07       Impact factor: 7.124

10.  Risk factors and clinical features of acute pulmonary embolism in children from the community.

Authors:  Charlie Yue Wang; Vera Ignjatovic; Peter Francis; Timothy Cain; Franz Babl; Remi Kowalski; Andrew Cochrane; Paul Monagle
Journal:  Thromb Res       Date:  2015-12-10       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.